卫光生物
(002880)
| 流通市值：45.00亿 | | | 总市值：45.00亿 |
| 流通股本：2.27亿 | | | 总股本：2.27亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 656,849,401.49 | 449,056,876.75 | 221,871,720.94 | 1,266,661,537.66 |
| 营业收入 | 656,849,401.49 | 449,056,876.75 | 221,871,720.94 | 1,266,661,537.66 |
| 二、营业总成本 | 559,871,953.61 | 394,950,442.23 | 180,979,840.59 | 976,684,778.23 |
| 营业成本 | 418,034,988.98 | 302,676,107.75 | 138,141,105.22 | 768,051,323.71 |
| 税金及附加 | 9,788,306.7 | 6,727,804.68 | 2,381,997.03 | 10,901,244.6 |
| 销售费用 | 16,752,822.2 | 10,422,632.28 | 4,150,959.32 | 36,106,311.62 |
| 管理费用 | 69,348,270.47 | 44,379,220.21 | 20,945,094.47 | 95,014,067.84 |
| 研发费用 | 33,392,877.65 | 21,619,740.99 | 11,119,422.48 | 46,023,648.08 |
| 财务费用 | 12,554,687.61 | 9,124,936.32 | 4,241,262.07 | 20,588,182.38 |
| 其中:利息费用 | 13,372,878.54 | 9,123,816.16 | 4,294,295.34 | 21,674,813.77 |
| 其中:利息收入 | 216,826.46 | 192,383.52 | 138,006.14 | 1,261,719.08 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | - | 1,870,660.37 |
| 加:投资收益 | 4,945,253.42 | 3,884,159.47 | 1,510,482.05 | 3,773,426.16 |
| 资产减值损失(新) | -2,515,800.05 | - | - | - |
| 信用减值损失(新) | -128,170.51 | -2,104,615.67 | -4,892,938.48 | -25,044,059.98 |
| 其他收益 | 5,387,075.33 | 3,873,885.17 | 1,817,943.12 | 13,435,128.48 |
| 四、营业利润 | 104,665,806.07 | 59,759,863.49 | 39,327,367.04 | 284,011,914.46 |
| 加:营业外收入 | 173,263.27 | 171,433.24 | 12,944.74 | 140,382.3 |
| 减:营业外支出 | 1,712,555.59 | 678,034 | 162,802.61 | 1,129,343.11 |
| 五、利润总额 | 103,126,513.75 | 59,253,262.73 | 39,177,509.17 | 283,022,953.65 |
| 减:所得税费用 | 21,798,528.83 | 14,624,798.29 | 8,407,548.69 | 37,231,859.29 |
| 六、净利润 | 81,327,984.92 | 44,628,464.44 | 30,769,960.48 | 245,791,094.36 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 81,327,984.92 | 44,628,464.44 | 30,769,960.48 | 245,791,094.36 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 81,227,658.22 | 44,385,904.7 | 30,982,974.04 | 246,320,739.85 |
| 少数股东损益 | 100,326.7 | 242,559.74 | -213,013.56 | -529,645.49 |
| 扣除非经常损益后的净利润 | 81,281,732.34 | 43,347,787.34 | 30,880,984.38 | 238,651,552.88 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.36 | 0.2 | 0.14 | 1.09 |
| (二)稀释每股收益 | 0.36 | 0.2 | 0.14 | 1.09 |
| 九、综合收益总额 | 81,327,984.92 | 44,628,464.44 | 30,769,960.48 | 245,791,094.36 |
| 归属于母公司股东的综合收益总额 | 81,227,658.22 | 44,385,904.7 | 30,982,974.04 | 246,320,739.85 |
| 归属于少数股东的综合收益总额 | 100,326.7 | 242,559.74 | -213,013.56 | -529,645.49 |
| 公告日期 | 2026-10-28 | 2026-08-14 | 2026-04-27 | 2026-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |